Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Timothy J, Kennedy"'
Autor:
Emma Vail, Ankur P. Choubey, H. Richard Alexander, David A. August, Abril Berry, Patrick M. Boland, Mariam F. Eskander, Miral S. Grandhi, Brittany Haliani, Haejin In, Timothy J. Kennedy, Russell C. Langan, Jason C. Maggi, Henry A. Pitt, Shridar Ganesan, Brett L. Ecker
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Several cytotoxic chemotherapies have demonstrated efficacy in improving recurrence‐free survival (RFS) following resection of Stage II–IV colorectal cancer (CRC). However, the temporal dynamics of response to such adjuvant th
Externí odkaz:
https://doaj.org/article/c7d6c4918adb470e867663524ca12d6d
Autor:
Joshua D. Greendyk, William E. Allen, H. Richard Alexander, Toni Beninato, Mariam F. Eskander, Miral S. Grandhi, Timothy J. Kennedy, Russell C. Langan, Jason C. Maggi, Subhajyoti De, Colin M. Court, Brett L. Ecker
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 3058 (2023)
Several molecular biomarkers have been identified to guide induction treatment selection for localized pancreatic ductal adenocarcinoma (PDAC). SMAD4 alterations and low GATA6 expression/modified “Moffitt” basal-like phenotype have each been asso
Externí odkaz:
https://doaj.org/article/3a65d68a4ab643f699fba7f3039a0806
Autor:
Stephanie H. Greco, MD, David A. August, MD, Mihir M. Shah, MD, Chunxia Chen, MS, Dirk F. Moore, PhD, Monika Masanam, BA, Amber L. Turner, MPH, Salma K. Jabbour, MD, Parisa Javidian, MD, Miral S. Grandhi, MD, Timothy J. Kennedy, MD, H. Richard Alexander, MD, Darren R. Carpizo, MD, PhD, Russell C. Langan, MD
Publikováno v:
Surgery Open Science, Vol 3, Iss , Pp 22-28 (2021)
Background: Neoadjuvant therapy (NAT) for T1/T2 pancreatic adenocarcinoma (PDAC) prior to pancreaticoduodenectomy remains controversial. We compared positive margin rates in patients with clinical T1&T2 tumors who did and did not receive NAT. Methods
Externí odkaz:
https://doaj.org/article/5bf9b49f411748fd876da8ad503e6596
Autor:
Victor P. Gazivoda, Aaron W. Kangas-Dick, Alissa A. Greenbaum, Joshua Roshal, Chunxia Chen, Dirk F. Moore, Russell C. Langan, Timothy J. Kennedy, Christine Minerowicz, H. Richard Alexander
Publikováno v:
Journal of Surgical Research. 277:131-137
Frequency of PD-L1 expression and the role of immunotherapy in malignant peritoneal mesothelioma (MPM) have not been well characterized. The purpose of this study was to determine PD-L1 expression in patients with MPM and perform an exploratory analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f5759527b3ba3ba344421572a01beed
https://doi.org/10.1016/j.jss.2022.04.005
https://doi.org/10.1016/j.jss.2022.04.005
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 1, Pp 308-315 (2017)
The treatment of gastric cancer requires a multimodal approach to decrease the risk of locoregional and distant recurrence. The optimal timing of chemotherapy, surgery, and radiation therapy continues to be explored in ongoing trials. In the United S
Externí odkaz:
https://doaj.org/article/ca1ea5fad5e14070801f3ca3d45fe949
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma
Autor:
Rachit, Kumar, Leila, Tchelebi, Christopher J, Anker, Navesh, Sharma, Nancy A, Bianchi, Jadranka, Dragovic, Karyn A, Goodman, Joseph M, Herman, Yixing, Jiang, William E, Jones, Timothy J, Kennedy, Percy, Lee, Madappa, Kundranda, Suzanne, Russo, William, Small, Wonsuk W, Suh, Nelson, Yee, Salma K, Jabbour
Publikováno v:
American Journal of Clinical Oncology. 45:391-402
The objective of this study was to systematically evaluate the data regarding the use of neoadjuvant, perioperative, surgical, and adjuvant treatment options in localized gastric cancer patients and to develop Appropriate Use Criteria recommended by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c9c8b7c49ad7f36e6a458fd64a1c89c
https://doi.org/10.1097/coc.0000000000000930
https://doi.org/10.1097/coc.0000000000000930
Autor:
Mutlay Sayan, Nikhil Yegya-Raman, Stephanie H. Greco, Bin Gui, Andrew Zhang, Anupama Chundury, Miral S. Grandhi, Howard S. Hochster, Timothy J. Kennedy, Russell C. Langan, Usha Malhotra, Vinod K. Rustgi, Mihir M. Shah, Kristen R. Spencer, Darren R. Carpizo, John L. Nosher, Salma K. Jabbour
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide, with a majority of HCC patients not suitable for curative therapies. Approximately 70% of initially diagnosed patients cannot undergo surgical resection or tran
Externí odkaz:
https://doaj.org/article/69414f7af8d84fdd8c7ca029ca8aca54
Autor:
Pranay S. Ajay, Caitlin P. Sok, Subir Goyal, Jeffery M. Switchenko, Felipe B. Maegawa, Theresa W. Gillespie, Chrystal M. Paulos, Gregory B. Lesinski, David A. Kooby, Timothy J. Kennedy, Mihir M. Shah
Publikováno v:
Journal of Surgical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65f7a50c2d5190c42627805a6d744105
https://doi.org/10.1002/jso.27297
https://doi.org/10.1002/jso.27297
Autor:
Pranay S. Ajay, Rachel NeMoyer, Subir Goyal, Jeffery M. Switchenko, Yong Lin, Salma K. Jabbour, Darren R. Carpizo, Chrystal M. Paulos, Timothy J. Kennedy, Mihir M. Shah
Publikováno v:
Journal of Surgical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fab7d0f99539726e70ac7d567157382c
https://doi.org/10.1002/jso.27276
https://doi.org/10.1002/jso.27276
Autor:
Kristen Spencer, Howard S. Hochster, Anupama Chundury, H. Richard Alexander, Prateek Gulhati, L.D. Berim, David A. August, Timothy J. Kennedy, Swati Mamidanna, Salma K. Jabbour, Russell C. Langan, Matthew P. Deek, Mutlay Sayan, Patrick McKay Boland, Shane S. Neibart, Miral S. Grandhi
Publikováno v:
J Gastrointest Oncol
BACKGROUND: Neoadjuvant chemoradiotherapy can provide downstaging and improve margin negativity for borderline resectable and resectable pancreatic adenocarcinoma [(B)RPC]. Little is known about the relative efficacy of capecitabine (CAPE)-based vs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67419012b91af5ce7072913cb45669da
https://doi.org/10.21037/jgo-21-503
https://doi.org/10.21037/jgo-21-503